London Vision Clinic
7
1
2
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
100%
1 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Treatment of Vision Disturbances Due to Corneal Irregularities by Trans-epithelial Optical Phototherapeutic Keratectomy (TE-oPTK)
Role: lead
Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser
Role: lead
VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia
Role: lead
Repeatability and Reproducibility of the ArcScan Insight 100 VHF Digital Ultrasound
Role: lead
Using the VisuMax Femtosecond Laser System to Perform SMILE Optimized for Presbyopia by Modulation of Postoperative Spherical Aberration
Role: lead
Repeatability, Reproducibility and Comparison of Cirrus OCT, RTVue OCT, MS-39 OCT, and Insight 100 VHFDU
Role: lead
Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction
Role: collaborator
All 7 trials loaded